Halozyme Therapeutics Inc. buy StockNews.com
Start price
16.11.25
/
50%
€60.12
Target price
16.11.26
-
Performance (%)
20.09%
Price
07.08.26
€89.18
Summary
This prediction is currently active. The BUY prediction by StockNews_com currently has a performance of 20.09%. This prediction currently runs until 16.11.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 24.588% | 24.588% |
| iShares Core DAX® | 2.573% | 3.502% |
| iShares Nasdaq 100 | 4.858% | 0.654% |
| iShares Nikkei 225® | 5.590% | -0.246% |
| iShares S&P 500 | 3.250% | 2.083% |
Comments by StockNews_com for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for HALO provided by MarketBeat